Document is current
Any future updates will be listed below
-
Authors
Kim, Young-Chan https://orcid.org/0000-0001-6865-2804
Han, Jae-Wook https://orcid.org/0000-0002-6116-598X
Jang, Won-Seok https://orcid.org/0009-0005-1784-7368
Kim, Sang-Wook https://orcid.org/0009-0005-8072-2891
Kwak, Ki-Hyeon https://orcid.org/0009-0006-0166-7343
Kwon, Soon-Jai https://orcid.org/0000-0002-7197-0704
Kwon, Young-Do https://orcid.org/0009-0006-1534-5919
Na, Young-Seok https://orcid.org/0009-0008-3045-1319
Shin, Han-Sang https://orcid.org/0009-0009-8952-1884
Shin, Yong-Seon https://orcid.org/0009-0004-6429-8448
Song, Hoo-Rim https://orcid.org/0000-0001-8927-0530
Song, Min-Kyu https://orcid.org/0000-0002-9382-5743
Kim, Dong-Wook https://orcid.org/0009-0008-7576-292X
-
Funding
Funding for this research was provided by:
Bukwang Pharmaceutical Co., Ltd
- License Information
-
More Information
Article History
Received: 4 August 2026
Accepted: 9 September 2026
First Online: 14 September 2026
Declarations
Ethics approval and consent to participate: This study was conducted in accordance with the Declaration of Helsinki. The protocol and analysis plan were approved by the Public Institutional Review Board Designated by the Ministry of Health and Welfare (approval no. P01-2026-01-01-001) on 2 January 2026, before study data abstraction. The requirement for written informed consent was waived by the IRB because the study used de-identified medical records without patient contact.
Consent for publication: Not applicable.
Competing interests: YCK received compensation from Bukwang Pharmaceutical Co., Ltd. for manuscript preparation related to this study. DWK, JWH, WSJ, SWK, KHK, SJK, YDK, YSN, HSS, YSS, HRS, and MKS received research funding from Bukwang Pharmaceutical Co., Ltd. for conducting the study at their respective sites. The authors declare no other competing interests.
